Clinical trial
WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation (PROTECT AF)
NCT00129545 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation (PROTECT AF)
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 28, 2005
- Completion date
- May 31, 2014
- Enrollment
- 800 (actual)
- Sites
- 62
Conditions
As the registry lists them; a condition with its own page is linked.